Neuroblastoma Clinical Trials in Richmond, Virginia

3 studies are recruiting for neuroblastoma in Richmond, Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

    The purpose of this study is to evaluate the investigational drug, silmitasertib (a pill taken by mouth), in combination with FDA approved drugs for solid tumors. An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authori…

    Stage
    Phase 1
    Ages
    Up to 30
    Site
    Virginia Commonwealth University, Richmond, Virginia
    Locations
    23 in total
    Run by
    Milton S. Hershey Medical Center

    See if you can join NCT06541262 on ClinicalTrials.gov

  2. Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

    This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Lor…

    Stage
    Phase 3
    Ages
    1 to 30
    Site
    VCU Massey Comprehensive Cancer Center, Richmond, Virginia
    Locations
    164 in total
    Run by
    Children's Oncology Group

    See if you can join NCT03126916 on ClinicalTrials.gov

  3. Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

    This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles of multi-agent chemotherapy. Naxitamab will be ad…

    Stage
    Phase 2
    Ages
    1 to 21
    Site
    Virginia Commonwealth University, Richmond, Virginia
    Locations
    26 in total
    Run by
    Giselle Sholler

    See if you can join NCT05489887 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.